BetaGlue Therapeutics

Milan, Italy · Founded 2009 · Privately Held (backing)

Developer of a medical platform designed to provide a targeted approach in the treatment of cancer. BetaGlue Therapeutics is based in Milan, Italy and was founded in 2009. Its last reported valuation was $25.3 million in Jul 2022. It has raised $49 million.

Last reported valuation

$25.3M

Oct 2026

Priced at

—

Total raised

$49.0M

Last round

—

How much has BetaGlue Therapeutics raised?

$49.0Macross 0 recorded rounds

Free account

More of BetaGlue Therapeutics with a free account

·The complete investor list: 14 names
·Watch BetaGlue Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

BetaGlue Therapeutics investors

14 investors are on record for BetaGlue Therapeutics, including European Innovation Council, LIFTT, NEVA SGR and Panakes Partners.

For fundraisers

Raising for a company like BetaGlue Therapeutics?

14 investors have backed BetaGlue Therapeutics.

See all 14 investors →

Frequently asked about BetaGlue Therapeutics

How much has BetaGlue Therapeutics raised?: BetaGlue Therapeutics has raised $49.0M in total across 0 recorded funding rounds.